Pathophysiology of autonomic dysreflexia: Long-term treatment with terazosin in adult and paediatric spinal cord injury patients manifesting recurrent dysreflexic episodes

Spinal Cord

Volumn 36, Issue 11, 1998, Pages 761-770

  Vaidyanathan, S ^a   Soni, B M ^a   Sett, P ^a   Watt, J W H ^a   Oo, T ^a   Bingley, J ^a  

^a District General Hospital   (United Kingdom)

Author keywords

Autonomic dysreflexia; Remodelling of spinal cord circuits; Spinal cord injury; Terazosin; Tetraplegia

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; TERAZOSIN;

ADOLESCENT; ADULT; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC DYSFUNCTION; CHILD; CLINICAL ARTICLE; DROWSINESS; FEMALE; FLUSHING; FOLLOW UP; HEADACHE; HUMAN; INTERVIEW; MALE; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PATHOLOGICAL REFLEX; PREGANGLIONIC NERVE CELL; PRIORITY JOURNAL; SPINAL CORD INJURY; SWEATING; SYMPTOM; VERTIGO;

EID: 0031768648     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100680     Document Type: Article

References (29)

1. Moeller BA Jr, Scheinberg D. Autonomic dysreflexia in injuries below the sixth thoracic segment. J Am Med Assoc 1973; 224: 1295.
2. Eltorai I et al. Fatal cerebral haemorrhage due to autonomic dysreflexia in a tetraplegic patient Case report and review. Paraplegia 1992; 30: 355-360.
3. Vaidyanathan S, Soni BM, Krishnan KR. Autonomic dysreflexia in a traumatic tetraplegic precipitated by the sexual act. J Sex Health 1994; 4: 93.
4. Consortium for Spinal Cord Medicine. Acute Management of Autonomic Dysreflexia: Adults with spinal cord injury presenting to health-care facilities. Clinical Practice Guidelines. February 1997; Paralyzed Veterans of America, Washington, DC, USA.
5. Cassam AK, Llewellyn-Smith IJ, Weaver LC. Catecholamine enzymes and neuropeptides, are expressed in fibres and somata in the intermediate gray matter in chronic spinal rats. Neuroscience 1997; 78: 829-841.
6. Krassioukov AV, Weaver LC. Morphological changes in sympathetic preganglionic neurons after spinal cord injury in rats. Neuroscience 1996; 70: 211-225.
7. Mathias CJ, Frankel HL. The cardiovascular system in tetraplegia and paraplegia. In Handbook of Clinical Neurology Frankel HL (ed), Vol. 17, Elsevier Science Publishers, Amsterdam. pp. 435-456.
8. Krenz NR, Weaver LC. Sprouting of primary afferent fibres after spinal cord transection in the rat. Neuroscience (in press).
9. Elliott HL. Adverse reactions profile: 14. Alpha-blockers. Prescribers' J 1996; 36: 154-158.
10. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary. September 1997; 34: 354.
11. Weaver LC, Cassam AK, Krassioukov AV, Llewellyn-Smith IJ. Changes in immunoreactivity for growth associated protein-43 suggest reorganization of synapses on spinal sympathetic neurons after cord transection. Neuroscience 1997; 81: 535-551.
12. Karlsson A-K et al. Regional sympathetic function in high spinal cord injury during mental stress and autonomic dysreflexia. Brain 1998; (in press).
13. Arnold JMO, Feng Q-P, Delaney GA, Teasell RW. Autonomic dysreflexia in tetraplegic patients: evidence for alpha-adrenoceptor hyper-responsiveness. Clin Auton Res 1995; 5: 267-270.
14. Maiorov DN, Krenz NR, Krassioukov AV, Weaver LC. Role of spinal NMDA and AMPA receptors in episodic hypertension in conscious spinal rats. Am J Physiol 1997; 273 (Heart Circ. Physiol. 42):
15. Maiorov DN, Krenz NR, Krassioukov AV, Weaver LC. Role of spinal NMDA and AMPA receptors in episodic hypertension in conscious spinal rats. Am J Physiol 1997; 273 (Heart Circ. Physiol. 42):
16. Bennett AD, Christensen MD., Hulsebosch CE. Dose response effects of AP-5 and NBQX on chronic central pain following spinal cord hemisection (Abstract). Neurosci Abst 1996; 22: 1369.
17. Llewellyn-Smith IJ et al. Glutamate- and GABA-immunoreactive synapses on sympathetic preganglionic neurons caudal to a spinal cord transection in rats. Neuroscience 1997; 80: 1225-1235.
18. Vaidyanathan S et al. A review of the readmissions of tetraplegic patients to the Regional Spinal Injuries Centre, Southport, United Kingdom between January 1994 and December 1995. Spinal Cord 1998; (in press).
19. Chancellor MB, Erhard MJ, Hirsch IH, Stass WE. Prospective evaluation of terazosin for the treatment of autonomic dysreflexia. J Urol 1994; 151: 111-113.
20. McKiernan JM, Lowe FC. Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia. South Med J 1997; 90: 509-513.
21. Kaplan SA, Meade-D'Alisera P, Qinones S, Soldo KA. Doxazosin in physiologically and pharmacologically normotensive men with benign prostate hyperplasia. Urology 1995; 46: 512-517.
22. Kaplan SA, Soldo KA, Olsson CA. Terazosin and doxazosin in normotensive men with symptomatic prostatism: a pilot study to determine the effect of dosing regimen on efficacy and safety. Euro Urol 1995; 28: 223-228.
23. Cohen J. Long-term efficacy and safety of terazosin. J Clin Pharm 1993; 33: 272-278.
24. Lowe FC. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis. Urology 1994; 44: 46-51.
25. Baunman WA et al. Coronary artery disease: Metabolic risk factors and latent disease in individuals with paraplegia. Mt Sinai J Med (NY) 1992; 59: 163-168.
26. Bauman WA et al. Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury. Paraplegia 1992; 30: 697-703.
27. 1-adrenergic receptors. Cell Signal 1996; 8: 323-333.
28. Krassioukov AV, Weaver LC. Episodic hypertension due to autonomic dysreflexia in acute and chronic spinal cord-injured rats. Am J Physiol 1995; 268 (Heart Circ. Physiol. 37): H2077-E2083.
29. Krassioukov AV, Weaver LC. Reflex and morphological changes in spinal preganglionic neurons after cord injury in rats. Clin Exper Hyperten 1995; 17: 361-373.